- 18 September, 2026
Ikris Pharma Network Launches Digital Platform for Named Patient Program
Named Patient Program brings medicine requests, regulatory documentation, and shipment tracking into a single platform for healthcare professionals and eligible
Ikris Pharma Network Announces the Availability of Triokris™ (Trientine Dihydrochloride) to Support Patients Living With Wilson’s Disease
Noida, India — 15 January, 2026 – Ikris Pharma Network announced the availability of Triokris™ (Trientine Dihydrochloride 250 mg Capsules),